Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
843 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05702944 | The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma | recruiting | Phase 4 | 24 | Seoul National University HospitalOTHER | 1 | Jun 12, 2025 | clinicaltrials |
| NCT06418412 | A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC | recruiting | — | 600 | National Cancer Centre, SingaporeOTHER | 3 | Jun 12, 2025 | clinicaltrials |
| NCT04566380 | ONO-4538 Phase II Rollover Study (ONO-4538-98) | recruiting | Phase 2 | 59 | Ono Pharmaceutical Co., Ltd.INDUSTRY | 3 | Jun 3, 2025 | clinicaltrials |
| NCT05333328 | OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk(INTERSTELLAR) | recruiting | Phase 4 | 418 | Gangnam Severance HospitalOTHER | 1 | May 22, 2025 | clinicaltrials |
| NCT05541822 | To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation | recruiting | Phase 2 | 178 | Abion IncINDUSTRY | 3 | May 22, 2025 | clinicaltrials |
| NCT03117036 | Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study III | recruiting | — | 600 | Samsung Medical CenterOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT05439278 | Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma | recruiting | Phase 3 | 178 | Severance HospitalOTHER | 1 | May 21, 2025 | clinicaltrials |
| NCT05394831 | A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC | recruiting | Phase 1 / Phase 2 | 150 | J Ints BioINDUSTRY | 3 | May 16, 2025 | clinicaltrials |
| NCT05763277 | Ate-Bev Early Response Prediction Model in Advanced HCC | recruiting | — | 170 | Seoul National University HospitalOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06911255 | Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma | recruiting | Phase 1 / Phase 2 | 24 | Yoon Jun KimOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT06969742 | Development and Application of Intervention Program to Improve Mental Health and Quality of Life of Solid Tumor Survivors and Caregivers | recruiting | N/A | 120 | National Cancer Center, KoreaOTHER_GOV | 1 | May 14, 2025 | clinicaltrials |
| NCT05795244 | Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC) | recruiting | Phase 2 | 30 | Yonsei UniversityOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06837792 | Trastuzumab Deruxtecan vs Endocrine Therapy in Low-HER2 HR+ Advanced Breast Cancer | recruiting | Phase 2 | 141 | Yonsei UniversityOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT06944457 | Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of MPD-1 in Patients With Advanced Solid Tumor | recruiting | Phase 1 | 24 | Pharosgen Co.,LtdINDUSTRY | 1 | Apr 25, 2025 | clinicaltrials |
| NCT05978492 | A Study of TXN10128 in Subjects With Solid Tumors | recruiting | Phase 1 | 96 | Txinno Bioscience Inc.INDUSTRY | 1 | Apr 24, 2025 | clinicaltrials |
| NCT04892693 | Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency | recruiting | Phase 2 | 70 | Seoul National University HospitalOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT05536128 | Evaluating the Efficacy and Safety of Fulvestrant Plus DNA Damage Repair Inhibitors After a CDK4/6 Inhibitor(Post-CDK) | recruiting | Phase 2 | 64 | Seoul National University HospitalOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT03592472 | A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV) | recruiting | Phase 3 | 413 | Xynomic Pharmaceuticals, Inc.INDUSTRY | 6 | Apr 13, 2025 | clinicaltrials |
| NCT04775485 | A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors(FIREFLY-1) | recruiting | Phase 2 | 141 | Day One Biopharmaceuticals, Inc.INDUSTRY | 11 | Apr 10, 2025 | clinicaltrials |
| NCT05588648 | Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma | recruiting | Phase 1 / Phase 2 | 48 | MedPacto, Inc.INDUSTRY | 2 | Apr 10, 2025 | clinicaltrials |
| NCT06920810 | Viscum Album for TNBC on Adjuvant Pembrolizumab(TNBNOBA) | recruiting | Phase 4 | 40 | Ilsan Cha hospitalOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT05421650 | Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr | recruiting | N/A | 240 | CHA UniversityOTHER | 5 | Apr 9, 2025 | clinicaltrials |
| NCT06505577 | Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study | recruiting | — | 600 | Incheon St.Mary's HospitalOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT06911333 | AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors(AD1208) | recruiting | Phase 1 / Phase 2 | 36 | Avelos Therapeutics Inc.INDUSTRY | 1 | Apr 4, 2025 | clinicaltrials |
| NCT06840106 | Nasal Steam Therapy for Post-extubation Respiratory Events(PURE) | recruiting | N/A | 66 | Ilsan Cha hospitalOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT06907160 | Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer | recruiting | — | 100 | Yonsei UniversityOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT05784688 | Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 140 | TiumBio Co., Ltd.INDUSTRY | 2 | Mar 30, 2025 | clinicaltrials |
| NCT05816655 | Comparison of Clinical Efficacy Between Letrozole + Ribociclib and Fulvestrant + Letrozole + Ribociclib in Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer | recruiting | Phase 2 | 202 | Korea University Guro HospitalOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT06780735 | Surgical Outcome of BCS Using ICG-F in Breast Cancer Patients After Preoperative Chemotherapy | recruiting | N/A | 128 | National Cancer Center, KoreaOTHER_GOV | 1 | Mar 13, 2025 | clinicaltrials |
| NCT03579836 | Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic Cancer | recruiting | Phase 1 / Phase 2 | 75 | BeyondBio Inc.INDUSTRY | 1 | Mar 10, 2025 | clinicaltrials |
| NCT05093907 | A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer | recruiting | Phase 1 / Phase 2 | 27 | BeyondBio Inc.INDUSTRY | 1 | Mar 10, 2025 | clinicaltrials |
| NCT05769660 | A Study to Evaluate Safety and Efficacy of BEY1107 in Combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma Multiforme (GBM) | recruiting | Phase 1 | 12 | BeyondBio Inc.INDUSTRY | 1 | Mar 10, 2025 | clinicaltrials |
| NCT05704621 | Secondary Cytoreductive Surgery (CRS) in Patients With Relapsed Ovarian Cancer Who Have Progressed on PARP Inhibitor Maintenance(SOCCER-P) | recruiting | Phase 2 | 124 | Korea University Guro HospitalOTHER | 1 | Mar 6, 2025 | clinicaltrials |
| NCT06181929 | A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females | recruiting | N/A | 200 | Sang-Won UmOTHER | 1 | Mar 5, 2025 | clinicaltrials |
| NCT06855485 | Efficacy and Safety of HANAROSTEN® HOT Plumber™ With Z-EUSIT™ for Pancreatic Pseudocyst Drainage(ZEUS) | recruiting | N/A | 20 | Asan Medical CenterOTHER | 1 | Mar 3, 2025 | clinicaltrials |
| NCT06839716 | Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscopic/Robotic Gastrectomy | recruiting | N/A | 134 | Gangnam Severance HospitalOTHER | 1 | Feb 25, 2025 | clinicaltrials |
| NCT06841484 | Comparison of Full Robotic Instrumentation and Assistant-Controlled Laparoscopic Instrumentation in Robotic Distal Gastrectomy | recruiting | N/A | 36 | Gangnam Severance HospitalOTHER | 1 | Feb 24, 2025 | clinicaltrials |
| NCT05992220 | Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion(ALERT-HCC) | recruiting | Phase 2 | 138 | Asan Medical CenterOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06756061 | Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity(FRONTJAK-001) | recruiting | Phase 2 | 88 | Byung-Sik ChoOTHER | 1 | Feb 19, 2025 | clinicaltrials |
| NCT06778954 | Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy | recruiting | N/A | 48 | Gangnam Severance HospitalOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06293651 | Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid Tumors | recruiting | Phase 1 / Phase 2 | 125 | Dong-A ST Co., Ltd.INDUSTRY | 1 | Feb 12, 2025 | clinicaltrials |
| NCT05749900 | First-line Trastuzumab, Gemcitabine, Cisplatin and Nivolumab in Advanced HER2- Positive Biliary Tract Cancer: a Multicenter, Open-label, Single-arm Phase Ib/II Trial (HERBOT) | recruiting | Phase 1 / Phase 2 | 44 | Yonsei UniversityOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT05912569 | Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS | recruiting | N/A | 84 | Seoul National University HospitalOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT05222971 | Olaparib With or Without Durvalumab for DDR Gene Mutated Biliary Tract Cancer Following Platinum-based Chemotherapy(OPTIMUM) | recruiting | Phase 2 | 62 | Asan Medical CenterOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT06796517 | Immunotherapy in Lymphoma | recruiting | — | 72 | Sung-Soo ParkOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT06782984 | Drug Response Testing and Repurposing Using Glioblastoma Organoid | recruiting | — | 150 | Chungnam National University HospitalOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT06780748 | Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients | recruiting | Phase 2 | 30 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 17, 2025 | clinicaltrials |
| NCT06767579 | Comparison of the Incidence of Delirium Caused by Different Anesthetic Agents in Patients Undergoing Liver Transplantation | recruiting | — | 350 | Yonsei UniversityOTHER | 1 | Jan 10, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials